Di Martino P, Agniel R, David K, Templer C, Gaillard J L, Denys P, Botto H
Laboratoire ERRMECe (EA1391), Université de Cergy-Pontoise, 2 Avenue A. Chauvin, 95302 Pontoise cedex, France.
World J Urol. 2006 Feb;24(1):21-7. doi: 10.1007/s00345-005-0045-z. Epub 2006 Jan 6.
To determine the efficacy of the consumption of cranberry juice versus placebo with regard to the presence of in vitro bacterial anti-adherence activity in the urine of healthy volunteers. Twenty healthy volunteers, 10 men and 10 women, were included. The study was a double-blind, randomized, placebo-controlled, and cross-over study. In addition to normal diet, each volunteer received at dinner a single dose of 750 ml of a total drink composed of: (1) 250 ml of the placebo and 500 ml of mineral water, or (2) 750 ml of the placebo, or (3) 250 ml of the cranberry juice and 500 ml of mineral water, or (4) 750 ml of the cranberry juice. Each volunteer took the four regimens successively in a randomly order, with a washout period of at least 6 days between every change in regimen. The first urine of the morning following cranberry or placebo consumption was collected and used to support bacterial growth. Six uropathogenic Escherichia coli strains (all expressing type 1 pili; three positive for the gene marker for P-fimbriae papC and three negative for papC), previously isolated from patients with symptomatic urinary tract infections, were grown in urine samples and tested for their ability to adhere to the T24 bladder cell line in vitro. There were no significant differences in the pH or specific gravity between the urine samples collected after cranberry or placebo consumption. We observed a dose dependent significant decrease in bacterial adherence associated with cranberry consumption. Adherence inhibition was observed independently from the presence of genes encoding type P pili and antibiotic resistance phenotypes. Cranberry juice consumption provides significant anti-adherence activity against different E. coli uropathogenic strains in the urine compared with placebo.
为了确定饮用蔓越莓汁与饮用安慰剂相比,对健康志愿者尿液中体外细菌抗黏附活性的影响。纳入了20名健康志愿者,其中10名男性和10名女性。该研究为双盲、随机、安慰剂对照和交叉研究。除正常饮食外,每位志愿者在晚餐时接受单剂量750毫升的混合饮品,其中包括:(1)250毫升安慰剂和500毫升矿泉水;(2)750毫升安慰剂;(3)250毫升蔓越莓汁和500毫升矿泉水;(4)750毫升蔓越莓汁。每位志愿者按随机顺序依次服用这四种方案,每次方案改变之间至少有6天的洗脱期。饮用蔓越莓汁或安慰剂后早晨的首次尿液被收集起来用于支持细菌生长。六种尿路致病性大肠杆菌菌株(均表达1型菌毛;三种P菌毛基因标记papC呈阳性,三种papC呈阴性),这些菌株先前从有症状尿路感染患者中分离得到,在尿液样本中培养,并检测其体外黏附T24膀胱细胞系的能力。饮用蔓越莓汁或安慰剂后收集的尿液样本在pH值或比重方面没有显著差异。我们观察到饮用蔓越莓汁后细菌黏附呈剂量依赖性显著降低。黏附抑制的观察与编码P型菌毛的基因和抗生素耐药表型的存在无关。与安慰剂相比,饮用蔓越莓汁可使尿液中针对不同尿路致病性大肠杆菌菌株产生显著的抗黏附活性。